In8bio logo

In8bio Share Price (NASDAQ: INAB)

$2.2

-0.06

(-2.65%)

Last updated on

Check the interactive In8bio Stock chart to analyse performance

In8bio, Inc Key Stats

Check In8bio key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.26
Open
$2.26
Market Capitalization
$10.4M
Today's Volume
$33.6K
Revenue TTM
$0.0
EBITDA
$-21.1M
Earnings Per Share (EPS)
$-9.08
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-165.56%

Stock Returns calculator for In8bio Stock including INR - Dollar returns

The In8bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

In8bio investment value today

Current value as on today

₹19,951

Returns

₹80,049

(-80.05%)

Returns from In8bio Stock

₹85,333 (-85.33%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards In8bio Stock

-53%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for In8bio Stock from India on INDmoney has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in In8bio, Inc

  • Name

    Holdings %

  • BIOS CAPITAL MANAGEMENT, LP

    7.03%

  • Franklin Resources Inc

    4.66%

  • AIGH Capital Management, LLC

    3.68%

  • Alyeska Investment Group, L.P.

    2.02%

  • Stonepine Capital Management Llc

    2.02%

  • Vanguard Group Inc

    1.47%

Analyst Recommendation on In8bio Stock

Rating
Trend

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for In8bio(by analysts ranked 0 to 5 stars)

In8bio Share Price Target

What analysts predicted

Upside of 2540.91%

Target:

$58.10

Current:

$2.20

In8bio share price target is $58.10, a slight Upside of 2540.91% compared to current price of $2.20 as per analysts' prediction.

In8bio Stock Insights

  • Price Movement

    In the last 3 months, INAB stock has moved down by -49.2%
  • INAB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 155.6%
  • INAB vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 209.9%

In8bio Technicals Summary

Sell

Neutral

Buy

In8bio is currently in a neutral trading position according to technical analysis indicators.

In8bio, Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
In8bio, Inc logo
7.11%
-71.03%
-84.94%
-97.39%
-99.25%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About In8bio, Inc

IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases. Its products include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. The company also develops INB-619, a gamma-delta TCE targeting CD19 for both oncology and autoimmune diseases; INB-300, a nsCAR-enabled DeltEx product candidates targeting difficult liquid tumors and extracranial solid tumors; and INB-500, an induced pluripotent stem cell derived gamma-delta T cells that are in preclinical phase for treatment of cancer. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is based in New York, New York.
Organization
In8bio
Employees
18
CEO
Mr. Tai-Wei Ho
Industry
Health Technology

Key Management of In8bio, Inc

NameTitle
Mr. Tai-Wei Ho
Co-Founder, President, CEO & Director
Mr. Patrick McCall CPA
CFO & Secretary
Dr. Kate Rochlin Ph.D.
Chief Operating Officer
Dr. Lawrence S. Lamb Ph.D.
Executive VP, Co-Founder & Chief Scientific Officer

Important FAQs about investing in INAB Stock from India :

What is In8bio share price today?

In8bio share price today is $2.20 as on at the close of the market. In8bio share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for In8bio share?

In8bio share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. In8bio stock price today i.e. is closed at $2.20, lower by 86.82% versus the 52 week high.

How to invest in In8bio Stock (INAB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for In8bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in In8bio Shares that will get you 0.6818 shares as per In8bio share price of $2.20 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy In8bio Stock (INAB) from India?

Indian investors can start investing in In8bio (INAB) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in In8bio stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on In8bio share’s latest price of $2.20 as on August 30, 2025 at 1:29 am IST, you will get 4.5455 shares of In8bio. Learn more about fractional shares .

What are the returns that In8bio has given to Indian investors in the last 5 years?

In8bio stock has given -99.25% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?